Latest "ChemBridge Research Laboratories, Inc." News Stories

14:45 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "ChemBridge Research Laboratories, Inc." found in our extensive news archives from over 250 global news sources.

More Information about ChemBridge Research Laboratories, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ChemBridge Research Laboratories, Inc. for you to read. Along with our medical data and news we also list ChemBridge Research Laboratories, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of ChemBridge Research Laboratories, Inc. Companies for you to search.

Showing "ChemBridge Research Laboratories" News Articles 1–25 of 28,000+

Tuesday 25th September 2018

The Trump administration is going to review all fetal tissue research …

The Trump administration is going to review all fetal tissue research … #NBTInTheirWords

Infectious Bacteria Hibernate to Evade Antibiotics

NewsResearchers have discovered a surprising tactic of pathogenic bacteria when being attacked by antibiotics: hibernation.Con

Looking Ahead to Infrared

NewsA new infrared camera narrows the gap between basic and applied research in additive manufacturing.Contributed Author: 

LabRoots Releases New 2019 Media Kit, and Announces 2019 Virtual Event Schedule

LabRoots users can preview and register for all the 2019 virtual events, as well as watch all the 2018 events on demand. YORBA LINDA, Calif. (PRWEB) September 25, 2018 LabRoots, the leading provider of interactive and educational virtual events and webinars for researchers, scientists and doctors from around the world, announces their 2019 lineup of virtual events as they release their new 2019 m...

Mauna Kea Technologies SA (MKEA-FR): H1 results reflect continued focus on the US

goetzpartners securities Limited 25-Sep-2018 / 15:58 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clien...

Merck, Accenture team with Amazon to develop a research platform for early-stage drug development

The platform will be designed to help life sciences organizations improve productivity, efficiency, and innovation in early stage drug development, says Accenture executive.

The Trump administration has launched a comprehensive review of all research that involves fetal tissue, reopening an issue that has galvanized anti-abortion activists but worried scientists.

The Trump administration has launched a comprehensive review of all research that involves fetal tissue, reopening an issue that has galvanized anti-abortion activists but worried scientists.

In Zebrafish, a Way to Find New Cancer Therapies Targeting Tumor Modulators

NewsDespite more than 30 phase II clinical trials since 1985, there is no standard chemotherapy or drug regimen for adenoid cystic carcinoma.

Imfinzi is the First Immunotherapy to Demonstrate Significant Overall Survival Benefit in Unresectable, Stage III Lung Cancer

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of IMFINZI® (durvalumab) during the Presidential Symposium of the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Toronto, Canada. R...

Nuevolution (NUEV) - Pipeline and partnerships continue to strengthen

Edison Investment Research - Pharmaceutical & healthcare - Nuevolution: With the completion of the up-listing to the Nasdaq Stockholm main market and the successful gross SEK110m capital raise, Nuevolution continues to strengthen both its investor base and financial position. Amgen’s opt-in on the first programme in its multi-target collaboration and the identification of much sought-after s...

PMI: Taking Bold Action for Global Change: a Conversation on Tobacco Today and Transformation for Tomorrow

During the 2018 Concordia Annual Summit, taking place in September 24 & 25 in New York, André Calantzopoulos, CEO of Philip Morris International, delivered a speech highlighting the need to have a dialogue between the industry, leaders, policy-makers, scientists, medical, and public health professionals in order to provide the 1.1 billion people who s...

Trump administration launches review of scientific research involving fetal tissue

The Trump administration has launched a comprehensive review of all research that involves fetal tissue, reopening an issue that has galvanized anti-abortion activists but worried scientists.

Special Labs, Special Purposes

ArticleFor the most part, laboratories are great places to work. While the weeknight and weekend hours may not be enjoyable, and you probably still don’t have a window in your office, the work scientists and researchers complete in laboratories is fundamental to society. Of course, there are outliers to the stereotypical vision of a scientific laboratory—there are those that conduct unique wor...

Organs May Be Active Participants in Fighting Autoimmune Disease

NewsOrgans affected by autoimmune disease could be fighting back by “exhausting” immune cells that cause damage using methods similar to those used by cancer cells to escape detection.

Lyme Disease: Tick Bites Can Cause Infection in Less Than 24 Hours

NewsScientists from the Institut Pasteur used mice to study the transmission of bacteria by ticks infected with various European and North American species of Borrelia.

Reinvent Biologics Appoints David Drez, MD as a Chief Medical Officer

Fort Worth-based Reinvent Biologics announced the appointment of David Drez Jr., MD as Chief Medical Officer. As Chief Medical Officer, Drez will provide strategic leadership on all of Reinvent Biologics medical education and research activities. He will research and track current clinical trends and provide training and support to medical profess...

This Robotic Skin Makes Inanimate Objects Move

In Goethe’s poem “The Sorcerer’s Apprentice,” made world-famous by its adaptation in Disney’s Fantasia, a lazy apprentice, left to fetch water, uses magic to bewitch a broom into performing his chores for him. Now, new research from Yale has opened up the possibility of being able to animate—and automate—household objects by fitting them with a […]

The Plastic Surgery Foundation and MTF Biologics Open Applications for Allograft Tissue Research Grant Program

Partners fund advancements in tissue transplantation for plastic and reconstructive surgery The Plastic Surgery Foundation (PSF) and MTF Biologics are now accepting applications for their Allograft Tissue Research Grant Program. A collaborative effort from The PSF and MTF Biologics that beg

Conatus Pharmaceuticals Inc. (CNAT) Upcoming Presentations, Analysts Review and Target

Conatus Pharmaceuticals, Upcoming Presentations, Analysts Review and Target Traders News Source, a leading independent equity research, and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company, focused on the development and commercialization of novel medicines for the treatment of liv...

FDA Awarding Grants for Research into Rare Diseases

The FDA awarded the grants through the Orphan Products Clinical Trials Grants Program. 

Structure of Protein Responsible for Body Temperature Revealed

NewsFor the first time, scientists have revealed the atomic-level structure of a protein that may be a promising drug target for Alzheimer's and bipolar disorder.

Antibacterial Drones Effective Against Staph Infections

NewsGenomic "islands" that evolved from viruses can be converted into “drones” that disable Staphylococcus aureus.

Blockchain Market Continues to Grow as More Big Corporations Adopt the Technology

NEW YORK, September 25, 2018 /PRNewswire/ -- According to a report published by Grand View Research, the global blockchain technology market size is expected to Read more...

Blow-fill-seal Technology Market Worth $386.0 Million by 2023

CHICAGO, September 25, 2018 /PRNewswire/ -- According to the new market research report on the "Blow-fill-seal Technology Market by Material (Polypropylene & Polyethylene), Product (Bottles, Read more...

Holmusk Raises US$9.75 Million in Pre-Series A Financing

SINGAPORE, Sept. 25, 2018 /PRNewswire/ -- Holmusk, a Singapore-headquartered digital health and data analytics company with a global presence, today announced closing of US$9.75 million in Pre-Series A financing. The financing round included funding from Heritas Venture Fund as well as participation from new and existing investors. The funds allow Holmusk to expand its footprint in USA and Europe....

Quick Search


News Quicklinks